Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studies

被引:304
作者
Armstrong, April W. [1 ]
Harskamp, Caitlin T. [1 ]
Armstrong, Ehrin J. [2 ]
机构
[1] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95816 USA
[2] Univ Calif Davis, Dept Cardiovasc Med, Sacramento, CA 95816 USA
关键词
epidemiology; meta-analysis; metabolic syndrome; prevalence; psoriasis; risk factors; systematic review; CARDIOVASCULAR MORTALITY; NATIONAL-HEALTH; US ADULTS; PREVALENCE; RISK; DISEASE; DIAGNOSIS; MODERATE;
D O I
10.1016/j.jaad.2012.08.015
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Increasing population-based studies have suggested a relationship between psoriasis and metabolic syndrome. Objective: The objective of this study was to perform a systematic review and meta-analysis that synthesizes the epidemiologic associations between psoriasis and metabolic syndrome. Methods: We searched for observational studies from MEDLINE, EMBASE, and Cochrane Central Register from Jan 1, 1980 to Jan 1, 2012. We applied the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines in the conduct of this study. Results: We identified 12 observational studies with a total of 1.4 million study participants fulfilling the inclusion criteria, among whom 41,853 were patients with psoriasis. Based on random-effects modeling of cross-sectional and case-controlled studies, the pooled odds ratio (OR) for metabolic syndrome among patients with psoriasis was 2.26 (95% confidence interval [CI] 1.70-3.01) compared with the general population. Visual inspection of a funnel plot and formal analysis with the Egger test suggested publication bias and absence of small studies in the published literature (P = .03). A dose-response relationship was also observed between psoriasis severity and prevalence of metabolic syndrome. Limitations: No studies to date have assessed incidence of metabolic syndrome among patients with psoriasis. Conclusions: Compared with the general population, psoriasis patients have higher prevalence of metabolic syndrome, and patients with more severe psoriasis have greater odds of metabolic syndrome than those with milder psoriasis. (J Am Acad Dermatol 2013;68:654-62.)
引用
收藏
页码:654 / 662
页数:9
相关论文
共 44 条
[11]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[12]   Association between psoriasis and the metabolic syndrome [J].
Cohen, A. D. ;
Sherf, M. ;
Vidavsky, L. ;
Vardy, D. A. ;
Shapiro, J. ;
Meyerovitch, J. .
DERMATOLOGY, 2008, 216 (02) :152-155
[13]   Circulating levels of adiponectin, oxidized LDL and C-reactive protein in Portuguese patients with psoriasis vulgaris, according to body mass index, severity and duration of the disease [J].
Coimbra, Susana ;
Oliveira, Hugo ;
Reis, Flavio ;
Belo, Luis ;
Rocha, Susana ;
Quintanilha, Alexandre ;
Figueiredo, Americo ;
Teixeira, Frederico ;
Castro, Elisabeth ;
Rocha-Pereira, Petronila ;
Santos-Silva, Alice .
JOURNAL OF DERMATOLOGICAL SCIENCE, 2009, 55 (03) :202-204
[14]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[15]   Bias in meta-analysis detected by a simple, graphical test [J].
Egger, M ;
Smith, GD ;
Schneider, M ;
Minder, C .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7109) :629-634
[16]   Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Giles, WH ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359
[17]   AJC Editor's Consensus: Psoriasis and Coronary Artery Disease [J].
Friedewald, Vincent E. ;
Cather, Jennifer C. ;
Gelfand, Joel A. ;
Gordon, Kenneth B. ;
Gibbons, Gary H. ;
Grundy, Scott M. ;
Jarratt, Michael T. ;
Krueger, James G. ;
Ridker, Paul M. ;
Stone, Neil ;
Roberts, William C. .
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (12) :1631-1643
[18]   Metabolic syndrome and risk of incident cardiovascular events and death - A systematic review and meta-analysis of longitudinal studies [J].
Gami, Apoor S. ;
Witt, Brandi J. ;
Howard, Daniel E. ;
Erwin, Patricia J. ;
Gami, Lisa A. ;
Somers, Virend K. ;
Montori, Victor M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (04) :403-414
[19]   Prevalence and treatment of psoriasis in the United Kingdom - A population-based study [J].
Gelfand, JM ;
Weinstein, R ;
Porter, SB ;
Neimann, AL ;
Berlin, JA ;
Margolis, D .
ARCHIVES OF DERMATOLOGY, 2005, 141 (12) :1537-1541
[20]   Risk of myocardial infarction in patients with psoriasis [J].
Gelfand, Joel M. ;
Neimann, Andrea L. ;
Shin, Daniel B. ;
Wang, Xingmei ;
Margolis, David J. ;
Troxel, Andrea B. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (14) :1735-1741